Nifty

:

17138.10

Sensex

:

57515.13

-479.05 (-2.72%)
-1522.05 (-2.58%)

Login

Nifty
Sensex

:
:

17138.10
57515.13

-479.05 (-2.72%)
-1522.05 (-2.58%)

JB Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

63/99

BSE: 506943 | NSE: JBCHEPHARM

Watchlist

NSE BSE

1760.40

21-Jan-2022

Open
High
Low
Previous Close

1750.00
1766.00
1725.00
1750.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

48734
854.17
1985.00
956.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

13,600.10
28.94
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

13,601.90
0.94%
6.89

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.80
8.34
7.52

EBITDA CAGR (%)

10 Years
5 Years
3 Years

18.68
19.07
12.70

PAT CAGR (%)

10 Years
5 Years
3 Years

-4.06
19.47
32.29

P:E (Median)

8 Years
5 Years
3 Years

19.13
17.95
20.90

P:BV (Average)

8 Years
5 Years
3 Years

2.80
3.32
4.16

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.49
12.19
13.70

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var%
Net Sales 526.73 411.78 27.92% 546.30 489.62 11.58% 490.25 416.86 17.61% 500.34 384.96 29.97%
Expenses 412.04 306.04 34.64% 388.00 331.47 17.05% 364.38 325.73 11.87% 333.74 300.87 10.92%
EBITDA 114.68 105.74 8.45% 158.30 158.15 0.09% 125.87 91.14 38.11% 166.60 84.08 98.14%
EBIDTM 21.77% 25.68% 28.98% 32.30% 25.67% 21.86% 33.30% 21.84%
Other Income 19.56 8.19 138.83% 12.88 22.54 -42.86% 25.30 2.88 778.47% 55.86 16.02 248.69%
Interest 1.18 1.70 -30.59% 0.89 3.73 -76.14% 0.68 0.40 70.00% 1.08 0.85 27.06%
Depreciation 15.40 17.14 -10.15% 17.48 16.97 3.01% 16.19 16.69 -3.00% 17.05 16.55 3.02%
PBT 117.66 95.09 23.74% 152.82 159.99 -4.48% 134.30 66.92 100.69% 204.33 82.70 147.07%
Tax 29.26 24.11 21.36% 37.51 38.07 -1.47% 31.79 16.05 98.07% 52.66 20.53 156.50%
PAT 88.40 70.98 24.54% 115.31 121.93 -5.43% 102.51 50.87 101.51% 151.67 62.17 143.96%
PATM 16.78% 17.24% 21.11% 24.90% 20.91% 12.20% 30.31% 16.15%
EPS 11.44 9.18 24.62% 14.92 15.77 -5.39% 13.26 6.58 101.52% 19.62 8.04 144.03%

Description Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var%
Net Sales 593.01 443.56 33.69% 605.99 522.29 16.03% 528.46 443.57 19.14% 548.22 428.63 27.90%
Expenses 466.27 333.47 39.82% 442.31 366.86 20.57% 404.56 351.83 14.99% 377.22 339.04 11.26%
EBITDA 126.74 110.10 15.11% 163.68 155.42 5.31% 123.90 91.74 35.06% 170.99 89.59 90.86%
EBIDTM 21.37% 24.82% 27.01% 29.76% 23.44% 20.68% 31.19% 20.90%
Other Income 19.64 8.39 134.09% 12.97 22.69 -42.84% 25.35 3.17 699.68% 55.95 16.38 241.58%
Interest 1.22 1.72 -29.07% 0.94 3.75 -74.93% 0.69 0.50 38.00% 1.09 0.85 28.24%
Depreciation 15.73 17.45 -9.86% 17.85 17.29 3.24% 16.53 17.39 -4.95% 17.39 16.75 3.82%
PBT 129.43 99.33 30.30% 157.87 157.07 0.51% 132.02 67.02 96.99% 208.46 88.37 135.89%
Tax 31.54 25.41 24.12% 38.81 37.57 3.30% 31.21 16.95 84.13% 54.18 21.93 147.06%
PAT 97.89 73.92 32.43% 119.06 119.51 -0.38% 100.81 50.07 101.34% 154.28 66.45 132.17%
PATM 16.51% 16.67% 19.65% 22.88% 19.08% 11.29% 28.14% 15.50%
EPS 12.65 9.55 32.46% 15.38 15.45 -0.45% 13.02 6.49 100.62% 19.94 8.26 141.40%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 2,063.62 1,892.00 1,640.74 1,501.19 1,254.99 1,198.69 1,164.94 1,061.42 956.53 816.42 686.42 Net Sales Growth 21.16% 15.31% 9.30% 19.62% 4.70% 2.90% 9.75% 10.97% 17.16% 18.94% Cost Of Goods Sold 704.58 625.76 569.14 536.35 484.27 469.32 470.01 322.91 380.72 341.32 271.40 Gross Profit 1,359.04 1,266.24 1,071.61 964.83 770.72 729.38 694.93 738.51 575.81 475.10 415.02 GP Margin 65.86% 66.93% 65.31% 64.27% 61.41% 60.85% 59.65% 69.58% 60.20% 58.19% 60.46% Total Expenditure 1,498.16 1,339.66 1,272.50 1,212.75 1,072.79 980.15 939.21 868.48 802.49 705.00 622.22 Power & Fuel Cost - 62.60 61.54 63.29 58.28 54.89 55.28 53.02 46.61 39.75 29.89 % Of Sales - 3.31% 3.75% 4.22% 4.64% 4.58% 4.75% 5.00% 4.87% 4.87% 4.35% Employee Cost - 305.98 293.78 257.98 217.31 187.86 165.96 146.82 131.85 120.13 101.31 % Of Sales - 16.17% 17.91% 17.19% 17.32% 15.67% 14.25% 13.83% 13.78% 14.71% 14.76% Manufacturing Exp. - 134.52 129.40 139.89 130.97 122.68 119.24 223.30 102.28 61.62 52.90 % Of Sales - 7.11% 7.89% 9.32% 10.44% 10.23% 10.24% 21.04% 10.69% 7.55% 7.71% General & Admin Exp. - 41.82 46.11 49.84 49.82 39.08 32.06 29.92 28.78 25.76 27.03 % Of Sales - 2.21% 2.81% 3.32% 3.97% 3.26% 2.75% 2.82% 3.01% 3.16% 3.94% Selling & Distn. Exp. - 99.94 106.58 104.91 59.44 48.83 48.13 47.39 70.48 55.49 59.10 % Of Sales - 5.28% 6.50% 6.99% 4.74% 4.07% 4.13% 4.46% 7.37% 6.80% 8.61% Miscellaneous Exp. - 69.04 65.96 60.48 72.71 57.49 48.54 45.12 41.78 60.93 59.10 % Of Sales - 3.65% 4.02% 4.03% 5.79% 4.80% 4.17% 4.25% 4.37% 7.46% 11.74% EBITDA 565.45 552.34 368.24 288.44 182.20 218.54 225.73 192.94 154.04 111.42 64.20 EBITDA Margin 27.40% 29.19% 22.44% 19.21% 14.52% 18.23% 19.38% 18.18% 16.10% 13.65% 9.35% Other Income 113.60 115.92 49.57 40.23 56.21 49.51 55.68 10.41 37.54 25.96 28.51 Interest 3.83 7.19 3.16 4.57 3.41 5.00 10.29 6.65 5.93 5.24 21.78 Depreciation 66.12 67.36 65.09 54.82 55.95 46.26 40.41 37.60 27.17 24.40 22.30 PBT 609.11 593.71 349.56 269.28 179.04 216.78 230.69 159.10 158.49 107.74 48.63 Tax 151.22 146.62 71.42 87.22 51.04 43.82 51.49 45.52 25.56 22.81 166.52 Tax Rate 24.83% 24.70% 21.03% 32.39% 28.51% 20.21% 22.32% 28.61% 27.19% 21.17% 20.58% PAT 457.89 447.08 268.14 182.06 128.00 172.96 179.20 113.58 68.43 84.94 642.70 PAT before Minority Interest 457.89 447.08 268.14 182.06 128.00 172.96 179.20 113.58 68.43 84.94 642.70 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 22.19% 23.63% 16.34% 12.13% 10.20% 14.43% 15.38% 10.70% 7.15% 10.40% 93.63% PAT Growth 49.66% 66.73% 47.28% 42.23% -25.99% -3.48% 57.77% 65.98% -19.44% -86.78% EPS 59.24 57.84 34.69 23.55 16.56 22.38 23.18 14.69 8.85 10.99 83.14

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 2,275.68 2,042.52 1,774.73 1,643.20 1,413.77 1,368.32 1,231.58 1,144.21 1,021.86 866.13 801.87 Net Sales Growth 23.81% 15.09% 8.00% 16.23% 3.32% 11.10% 7.64% 11.97% 17.98% 8.01% Cost Of Goods Sold 805.50 701.50 630.80 596.46 542.41 552.00 491.41 341.40 413.95 371.52 320.07 Gross Profit 1,470.18 1,341.02 1,143.93 1,046.74 871.35 816.32 740.17 802.81 607.92 494.60 481.80 GP Margin 64.60% 65.66% 64.46% 63.70% 61.63% 59.66% 60.10% 70.16% 59.49% 57.10% 60.08% Total Expenditure 1,690.36 1,486.35 1,397.15 1,337.36 1,214.64 1,135.93 1,025.55 964.09 873.67 760.48 701.55 Power & Fuel Cost - 62.60 61.54 63.29 58.28 54.89 55.28 53.02 46.61 39.75 29.89 % Of Sales - 3.06% 3.47% 3.85% 4.12% 4.01% 4.49% 4.63% 4.56% 4.59% 3.73% Employee Cost - 340.60 322.92 288.18 251.10 217.34 175.31 159.56 143.67 130.05 112.66 % Of Sales - 16.68% 18.20% 17.54% 17.76% 15.88% 14.23% 13.94% 14.06% 15.02% 14.05% Manufacturing Exp. - 148.68 140.70 150.49 139.83 131.45 119.35 223.53 102.44 61.75 52.97 % Of Sales - 7.28% 7.93% 9.16% 9.89% 9.61% 9.69% 19.54% 10.02% 7.13% 6.61% General & Admin Exp. - 43.27 48.14 52.97 53.96 42.26 34.82 32.46 31.69 27.94 31.31 % Of Sales - 2.12% 2.71% 3.22% 3.82% 3.09% 2.83% 2.84% 3.10% 3.23% 3.90% Selling & Distn. Exp. - 113.22 116.95 113.59 87.44 78.27 72.72 75.13 73.59 56.04 68.65 % Of Sales - 5.54% 6.59% 6.91% 6.18% 5.72% 5.90% 6.57% 7.20% 6.47% 8.56% Miscellaneous Exp. - 76.46 76.11 72.38 81.61 59.72 76.65 79.01 61.72 73.44 68.65 % Of Sales - 3.74% 4.29% 4.40% 5.77% 4.36% 6.22% 6.91% 6.04% 8.48% 10.72% EBITDA 585.31 556.17 377.58 305.84 199.13 232.39 206.03 180.12 148.19 105.65 100.32 EBITDA Margin 25.72% 27.23% 21.28% 18.61% 14.09% 16.98% 16.73% 15.74% 14.50% 12.20% 12.51% Other Income 113.91 116.62 50.90 41.44 55.29 50.16 56.65 10.89 37.70 27.87 28.98 Interest 3.94 7.24 3.26 4.65 3.49 5.37 10.65 6.82 5.93 5.28 24.03 Depreciation 67.50 68.67 66.32 55.64 56.97 47.22 41.22 38.64 28.02 24.66 22.42 PBT 627.78 596.89 358.89 286.99 193.95 229.94 210.82 145.55 151.94 103.57 82.85 Tax 155.74 148.36 76.50 93.02 55.23 45.55 49.58 45.14 25.95 24.13 165.53 Tax Rate 24.81% 24.86% 21.93% 32.41% 28.48% 19.81% 23.52% 31.01% 29.68% 23.30% 19.63% PAT 472.04 447.96 272.04 193.47 138.34 184.06 161.14 100.41 61.50 79.44 677.91 PAT before Minority Interest 471.34 448.52 272.39 193.97 138.72 184.40 161.24 100.41 61.50 79.44 677.91 Minority Interest -0.70 -0.56 -0.35 -0.50 -0.38 -0.34 -0.10 0.00 0.00 0.00 0.00 PAT Margin 20.74% 21.93% 15.33% 11.77% 9.79% 13.45% 13.08% 8.78% 6.02% 9.17% 84.54% PAT Growth 52.30% 64.67% 40.61% 39.85% -24.84% 14.22% 60.48% 63.27% -22.58% -88.28% EPS 61.07 57.95 35.19 25.03 17.90 23.81 20.85 12.99 7.96 10.28 87.70

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 1,806.46 1,445.29 1,484.56 1,453.39 1,387.86 1,222.71 1,016.31 1,047.81 1,009.00 953.86 Share Capital 15.46 15.46 16.05 16.71 16.96 16.96 16.96 16.95 16.94 16.94 Total Reserves 1,791.00 1,429.83 1,468.52 1,436.67 1,370.90 1,205.74 999.35 1,030.82 991.95 936.74 Non-Current Liabilities 86.41 73.29 79.08 62.98 41.79 46.07 34.05 32.56 37.45 36.35 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.22 0.40 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.40 0.40 7.03 11.12 Long Term Provisions 12.57 7.39 5.73 9.67 8.88 10.20 12.03 12.19 8.23 8.27 Current Liabilities 645.74 493.55 763.27 711.89 666.97 735.89 398.40 261.56 226.38 182.51 Trade Payables 164.02 151.88 111.33 100.22 79.03 68.61 62.31 51.69 51.76 33.54 Other Current Liabilities 86.45 100.73 87.05 112.90 118.08 119.03 82.60 94.00 98.41 76.70 Short Term Borrowings 26.43 29.49 25.80 28.48 48.86 174.40 104.73 81.28 36.77 55.23 Short Term Provisions 368.83 211.45 539.10 470.29 421.00 373.85 148.76 34.59 39.43 17.05 Total Liabilities 2,538.61 2,012.13 2,326.91 2,228.26 2,096.62 2,004.67 1,448.76 1,341.93 1,272.83 1,172.72 Net Block 564.60 583.21 552.11 569.91 608.69 369.35 300.87 282.21 294.37 241.01 Gross Block 1,108.14 1,105.15 1,011.81 979.68 963.76 679.77 571.73 510.94 497.02 421.06 Accumulated Depreciation 543.54 521.95 459.70 409.78 355.07 310.42 270.86 228.74 202.65 180.05 Non Current Assets 742.49 805.74 804.94 781.26 941.36 891.59 604.38 378.00 352.44 331.38 Capital Work in Progress 25.57 16.17 15.09 17.40 3.76 134.89 55.17 46.32 4.81 39.00 Non Current Investment 145.88 202.42 228.84 182.92 318.81 364.38 230.72 38.86 38.98 38.79 Long Term Loans & Adv. 5.62 3.59 8.31 10.00 9.22 22.63 17.62 10.62 14.28 12.58 Other Non Current Assets 0.82 0.36 0.59 1.03 0.88 0.33 0.00 0.00 0.00 0.00 Current Assets 1,796.12 1,206.39 1,521.97 1,446.99 1,155.26 1,113.08 844.38 963.93 920.39 841.34 Current Investments 664.97 333.81 360.65 383.77 224.96 247.28 366.78 497.26 394.68 298.92 Inventories 278.91 232.04 208.10 175.81 159.96 133.29 128.47 111.23 89.89 90.80 Sundry Debtors 374.11 344.24 299.85 300.54 265.10 265.67 248.49 248.05 194.64 131.21 Cash & Bank 26.43 11.56 20.77 14.95 7.20 10.71 9.06 10.80 149.11 211.36 Other Current Assets 451.70 18.03 32.49 11.20 498.05 456.13 91.58 96.59 92.07 109.05 Short Term Loans & Adv. 428.83 266.71 600.11 560.72 485.82 453.62 91.20 96.39 91.92 108.65 Net Current Assets 1,150.38 712.84 758.71 735.10 488.29 377.19 445.98 702.37 694.01 658.83 Total Assets 2,538.61 2,012.13 2,326.91 2,228.25 2,096.62 2,004.67 1,448.76 1,341.93 1,272.83 1,172.72

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 1,809.72 1,435.49 1,480.12 1,441.56 1,363.67 1,183.84 994.87 1,042.81 1,020.27 969.95 Share Capital 15.46 15.46 16.05 16.71 16.96 16.96 16.96 16.95 16.94 16.94 Total Reserves 1,794.27 1,420.03 1,464.08 1,424.84 1,346.70 1,166.87 977.91 1,025.82 1,003.22 952.83 Non-Current Liabilities 72.47 62.72 64.84 45.66 26.98 31.02 32.62 31.93 40.45 39.52 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.22 0.40 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.40 0.40 7.03 12.14 Long Term Provisions 12.57 7.39 5.73 9.67 12.56 10.43 12.03 12.19 8.23 8.27 Current Liabilities 686.57 516.19 781.54 736.50 693.46 797.22 459.75 276.27 239.48 188.32 Trade Payables 186.92 167.97 117.37 110.39 98.98 90.85 77.51 60.75 60.51 37.09 Other Current Liabilities 89.82 102.67 93.10 119.75 122.15 138.73 103.74 98.06 101.15 78.75 Short Term Borrowings 32.64 29.49 25.80 29.29 48.86 193.02 126.88 81.71 37.28 55.23 Short Term Provisions 377.17 216.06 545.27 477.06 423.47 374.61 151.62 35.76 40.54 17.26 Total Liabilities 2,572.47 2,016.90 2,329.30 2,226.49 2,086.29 2,013.75 1,487.24 1,351.01 1,300.20 1,197.79 Net Block 633.65 651.26 620.93 639.50 679.44 440.22 328.56 310.55 334.41 276.31 Gross Block 1,182.55 1,177.43 1,084.83 1,053.76 1,038.55 753.75 601.67 540.54 537.46 456.51 Accumulated Depreciation 548.90 526.17 463.89 414.25 359.10 313.53 273.11 229.99 203.06 180.19 Non Current Assets 678.57 740.83 740.80 717.89 879.15 831.58 586.31 370.37 356.49 331.58 Capital Work in Progress 25.57 16.17 15.09 17.40 3.76 134.89 55.17 46.36 4.81 39.00 Non Current Investment 12.91 69.45 95.88 49.96 185.84 231.42 184.83 2.75 2.99 3.00 Long Term Loans & Adv. 5.62 3.59 8.31 10.15 9.43 22.63 17.74 10.71 14.28 13.27 Other Non Current Assets 0.82 0.36 0.59 0.88 0.67 2.43 0.00 0.00 0.00 0.00 Current Assets 1,893.89 1,276.08 1,588.51 1,508.59 1,207.14 1,182.16 900.94 980.65 943.71 866.22 Current Investments 664.97 333.81 360.65 383.77 224.96 247.28 366.78 497.26 394.68 298.92 Inventories 347.45 274.67 243.76 213.73 200.17 187.98 150.27 134.40 104.53 101.03 Sundry Debtors 389.02 345.43 308.22 300.73 265.97 272.64 262.35 235.51 191.27 136.05 Cash & Bank 30.85 30.95 36.80 29.92 13.39 12.90 25.19 11.81 156.23 219.53 Other Current Assets 461.61 18.89 33.23 12.94 502.66 461.34 96.35 101.68 96.99 110.69 Short Term Loans & Adv. 436.39 272.33 605.85 567.50 488.30 458.83 95.97 101.48 96.84 110.29 Net Current Assets 1,207.33 759.88 806.97 772.10 513.68 384.94 441.19 704.37 704.23 677.90 Total Assets 2,572.46 2,016.91 2,329.31 2,226.48 2,086.29 2,013.74 1,487.25 1,351.02 1,300.20 1,197.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 335.43 271.95 192.63 115.87 177.58 170.87 143.03 -11.65 80.41 850.80 PBT 593.71 339.56 269.28 179.04 216.78 230.69 159.10 93.99 107.74 809.22 Adjustment -56.41 15.19 26.87 14.73 10.01 -9.63 35.94 14.11 -6.43 3.51 Changes in Working Capital -61.45 4.34 -42.44 -39.95 -0.30 1.15 -14.04 -93.19 0.67 202.58 Cash after chg. in Working capital 475.85 359.10 253.70 153.82 226.50 222.22 181.00 14.90 101.98 1,015.31 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -140.41 -87.15 -61.08 -37.95 -48.91 -51.34 -37.97 -26.55 -21.57 -164.51 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -230.68 23.80 -27.93 -23.97 -42.45 -51.69 -121.72 -138.77 -111.73 -235.86 Net Fixed Assets -12.39 -94.42 -29.82 -29.56 -152.86 -187.76 -69.64 -55.43 -41.77 -69.55 Net Investments -274.62 53.26 -22.80 -22.92 67.89 -14.16 -61.38 -102.46 -95.95 -214.42 Others 56.33 64.96 24.69 28.51 42.52 150.23 9.30 19.12 25.99 48.11 Cash from Financing Activity -86.90 -305.48 -155.66 -59.44 -164.84 -97.46 -23.06 12.12 -30.93 -526.49 Net Cash Inflow / Outflow 17.86 -9.73 9.05 32.45 -29.71 21.72 -1.75 -138.31 -62.25 88.44 Opening Cash & Equivalents 6.37 16.11 7.09 -25.36 4.35 -14.50 10.80 149.11 211.36 122.92 Closing Cash & Equivalent 24.26 6.37 16.11 7.09 -25.36 7.23 9.06 10.80 149.11 211.36

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 314.78 275.75 194.33 122.92 201.13 140.41 126.66 -13.98 84.20 879.69 PBT 596.89 348.89 286.99 193.95 229.94 212.23 145.55 87.44 103.57 843.44 Adjustment -46.17 7.95 23.72 16.91 13.11 -1.40 38.51 20.75 -4.40 33.13 Changes in Working Capital -94.21 9.70 -51.47 -47.07 5.92 -16.96 -19.52 -93.71 9.47 167.35 Cash after chg. in Working capital 456.50 366.55 259.24 163.79 248.97 193.88 164.53 14.49 108.65 1,043.91 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -141.72 -90.80 -64.91 -40.87 -47.84 -53.47 -37.87 -28.47 -24.45 -164.22 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -230.68 23.93 -27.67 -20.68 -45.31 -27.62 -111.89 -142.50 -116.05 -260.92 Net Fixed Assets -12.39 -94.42 -29.82 -29.56 -152.86 -187.76 -69.64 -55.43 -41.77 -69.55 Net Investments -274.62 53.26 -22.80 -22.92 67.89 -14.16 -61.38 -102.46 -95.95 -214.42 Others 56.33 65.09 24.95 31.80 39.66 174.30 19.13 15.39 21.67 23.05 Cash from Financing Activity -87.42 -306.05 -155.74 -59.52 -183.84 -99.62 -1.39 12.04 -31.45 -526.12 Net Cash Inflow / Outflow -3.31 -6.38 10.92 42.72 -28.02 13.17 13.38 -144.43 -63.30 92.65 Opening Cash & Equivalents 25.75 32.14 21.24 -21.47 6.54 -5.46 11.81 156.23 219.53 126.89 Closing Cash & Equivalent 22.47 25.75 32.14 21.24 -21.47 9.42 25.19 11.81 156.23 219.53

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 233.75 187.02 185.02 173.91 163.62 144.15 119.84 123.66 119.10 112.59 ROA 19.65% 12.36% 7.99% 5.92% 8.43% 10.38% 8.14% 5.23% 6.95% 58.96% ROE 27.50% 18.30% 12.39% 9.01% 13.25% 16.01% 11.01% 6.65% 8.66% 77.13% ROCE 36.33% 22.96% 18.30% 12.50% 15.65% 19.14% 14.65% 9.09% 10.85% 87.21% Fixed Asset Turnover 1.71 1.55 1.51 1.29 1.46 1.86 1.99 1.92 1.80 1.72 Receivable days 69.29 71.64 72.99 82.25 80.81 80.55 84.22 83.37 71.93 135.90 Inventory Days 49.29 48.96 46.67 48.83 44.65 41.01 40.66 37.88 39.88 45.40 Payable days 43.73 39.24 32.65 32.75 29.00 27.03 25.03 24.67 24.46 26.27 Cash Conversion Cycle 74.85 81.36 87.01 98.33 96.46 94.52 99.85 96.57 87.35 155.03 Total Debt/Equity 0.01 0.02 0.02 0.02 0.04 0.14 0.10 0.09 0.05 0.07 Interest Cover 83.55 108.34 59.98 53.45 44.35 23.41 24.93 16.84 21.55 38.16

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 234.17 185.75 184.47 172.50 160.77 139.57 117.31 123.07 119.21 113.34 ROA 19.55% 12.53% 8.52% 6.43% 8.99% 9.21% 7.08% 4.64% 6.36% 61.71% ROE 27.64% 18.69% 13.28% 9.89% 14.48% 14.80% 9.86% 5.99% 8.07% 82.49% ROCE 36.53% 23.71% 19.59% 13.70% 16.87% 17.72% 13.49% 8.50% 10.41% 92.09% Fixed Asset Turnover 1.73 1.57 1.54 1.35 1.53 1.82 2.03 1.92 1.76 1.85 Receivable days 65.62 67.22 67.63 73.15 71.84 79.28 78.41 75.30 68.16 108.62 Inventory Days 55.59 53.31 50.81 53.43 51.77 50.12 44.83 42.16 42.80 47.97 Payable days 43.67 38.74 32.21 33.66 32.86 32.45 27.82 26.91 26.15 26.89 Cash Conversion Cycle 77.54 81.79 86.23 92.93 90.75 96.95 95.43 90.54 84.81 129.69 Total Debt/Equity 0.02 0.02 0.02 0.02 0.04 0.16 0.13 0.09 0.05 0.07 Interest Cover 83.43 108.09 62.74 56.54 43.81 20.80 22.33 15.74 20.61 36.10

Top Investors:

invesco india contra fund **

franklin india smaller companies fund

nippon life india trustee ltd -a/c nippon india small cap fund**

icici prudential multicap fund**

kotak mahindra life insurance company ltd

government pension fund global

Annual Reports:

News Update:

JB Chemicals & Pharmaceuticals to launch Molnupiravir 200 mg for Indian market
29th Dec 2021, 09:33 AM

Molnupiravir should be administered as soon as possible after a diagnosis of COVID-19 has been made, and within five days of symptom onset
Read More
JB Chem & Pharma - Quarterly Results
11th Nov 2021, 18:43 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback